SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001832928-24-000017
Filing Date
2024-02-16
Accepted
2024-02-16 16:33:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D feb2024_manning13d.htm SC 13D 48257
  Complete submission text file 0001832928-24-000017.txt   49876
Mailing Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654
Business Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654 (312) 929-0993
Cresco Labs Inc. (Filed by) CIK: 0001832928 (see all company filings)

IRS No.: 981505364 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654
Business Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654 (312) 929-0993
Cresco Labs Inc. (Subject) CIK: 0001832928 (see all company filings)

IRS No.: 981505364 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92428 | Film No.: 24648939
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)